Medicover first in Europe to launch pilot project aimed at identifying patients at risk of colorectal cancer

Medicover first in Europe to launch pilot project aimed at identifying patients at risk of colorectal cancer


Medicover Polska is testing the ColonFlag modern solution that will allow to effectively identify patients at risk for colorectal cancer. The tool determines the risk of intestinal lesions by further analysing the results of a commonly performed blood test. The pilot project is being developed in collaboration with Medial EarlySign, an Israeli company that creates machine-learning systems in the area of data-driven medicine.

ColonFlag is a solution that identifies patients who may experience gastrointestinal microbleeding caused by polyps or cancer. A positive result is an indication for colonoscopy.

ColonFlag helps make diagnostic decisions thanks to applying advanced AI algorithms to data from frequently performed laboratory tests. The programme analyses data such as the results of a CBC test and other data contained in electronic medical records.

- Dr Piotr Soszyński, Director of Medical Systems at Medicover Polska

This makes it possible for the tool to identify people who are in a high risk group and require further testing.

Colon cancer is the second most common cancer in women in Poland and the third among males. It is the fourth most common cause of death due to cancer. In Poland, the average survival rate after five years is slightly below 50%. If colorectal cancer is diagnosed at an early stage, the rate may even exceed 90%. Early detection has enormous importance for the successful treatment of colorectal cancer. ColonFlag can help us better identify patients in the high risk group. Thanks to this, referrals for colonoscopy may result in a better chance of detecting the disease and significantly improve the outcome of treatment.

- Dr Bożena Walewska-Zielecka, Medical Director at Medicover Polska

The success of the project may mean that Medicover Polska will begin using the ColonFlag tool in routine diagnostic procedures.

We are pleased to be working with Medicover on their first use of machine-learning algorithms to streamline the processes of diagnostic decision making. This is the first step towards integrating technology that will have a far-reaching impact on the work of doctors and medical service providers. It will give them tools to provide individualised care for patients in the high risk group. - Ori Geva, CEO of Medial EarlySign.
The pilot programme using the innovative method is being implemented at Medicover Centres in Warsaw and in the south of Poland. The single analysis is performed in Medicover patients between the ages of 50 and 75 who have had a complete blood count test performed for any reasons and agreed to participate in the project. Medial EarlySign is currently conducting clinical trials in more than 20 million patients in 14 institutions around the world.

Copy as a Plain Text


Related Stories
How much can we benefit from effective healthcare?


PLN 726 per employee for each employer, more than PLN 11 billion in savings to the Treasury, are the savings which can be achieved thanks to investment in effective, quality healthcare, according to the authors of the report: “Work. Health. Economics. A 2012-2016 Perspective”, prepared by Medicover Polska. However, experts point out that the key to success is to bring the healthcare model in line with the healthcare needs of the economically active. Therefore, the key objective of this year’s analysis was to answer the question “How healthy are employees in Poland?”
4D ultrasound – an advanced method for foetal imaging


Obligatory tests for pregnant women in Poland include 2D ultrasound scan, which is a non-invasive imaging ultrasound check. The scan gives the opportunity to detect any potential abnormalities in the foetus at different stages of pregnancy. Even more diagnostic possibilities are available with the new 4D method as it allows for dimensional imaging of the baby in real time.
10 platinum minutes for life


The “Safe Company” Anniversary Medical Rescue Championships
Skin exam after holidays


Melanoma is one of the most dangerous skin neoplasm that, in many cases, may give spreads at an early stage. At the moment, it is the most frequent cause of death due to skin cancer. Melanoma is visible on the skin very quickly at early stages of its development, therefore doctors recommend self-examination of pigmented moles once a month. In particular, we should pay attention to moles that are irregular in shape, of uneven edges, multi-colour, changing in a short time and exceed 5 mm. When any suspicious changes are noticed, it is advisable to see a doctor who will carry out relevant diagnostic tests – dermoscopy and video-dermoscopy.

Healthy baby - the challenge of modern times

In 2016, over 382,000 births were recorded in Poland [1]. Research shows that two thirds of parents feed their children the wrong diet and expand their children’s diet too quickly [2]. The knowledge on how to take proper care of infants is still insufficient, which increases the risk of disease in later years. That is why regular medical check-ups for a newborn baby are so important to ensure that his health and development are constantly assessed. Constant paediatric care also enables parents to deepen their knowledge about the best ways to take care of their child's health.